BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 16581697)

  • 1. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
    Rogers DF
    COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging mucus regulating drugs in inflammatory and allergic lung disease.
    Hauber HP; Zabel P
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):30-4. PubMed ID: 18473898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary mucus: Pediatric perspective.
    Rogers DF
    Pediatr Pulmonol; 2003 Sep; 36(3):178-88. PubMed ID: 12910578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway mucus hypersecretion in asthma: an undervalued pathology?
    Rogers DF
    Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.
    Singer M; Martin LD; Vargaftig BB; Park J; Gruber AD; Li Y; Adler KB
    Nat Med; 2004 Feb; 10(2):193-6. PubMed ID: 14716307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.
    Lai HY; Rogers DF
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of human calcium-activated chloride channel 1 gene is correlated with mucus overproduction in Chinese asthmatic airway.
    Wang K; Wen FQ; Feng YL; Ou XM; Xu D; Yang J; Deng ZP
    Cell Biol Int; 2007 Nov; 31(11):1388-95. PubMed ID: 17698377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin-producing elements and inflammatory cells.
    Jeffery P; Zhu J
    Novartis Found Symp; 2002; 248():51-68; discussion 68-75, 277-82. PubMed ID: 12568488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway.
    Chen YJ; Chen P; Wang HX; Wang T; Chen L; Wang X; Sun BB; Liu DS; Xu D; An J; Wen FQ
    Int Immunopharmacol; 2010 Jun; 10(6):685-93. PubMed ID: 20359552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells.
    Mata M; Sarriá B; Buenestado A; Cortijo J; Cerdá M; Morcillo EJ
    Thorax; 2005 Feb; 60(2):144-52. PubMed ID: 15681504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold temperature induces mucin hypersecretion from normal human bronchial epithelial cells in vitro through a transient receptor potential melastatin 8 (TRPM8)-mediated mechanism.
    Li M; Li Q; Yang G; Kolosov VP; Perelman JM; Zhou XD
    J Allergy Clin Immunol; 2011 Sep; 128(3):626-34.e1-5. PubMed ID: 21762971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases.
    Ha EV; Rogers DF
    Pharmacology; 2016; 97(1-2):84-100. PubMed ID: 26674354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms.
    Hewson CA; Edbrooke MR; Johnston SL
    J Mol Biol; 2004 Nov; 344(3):683-95. PubMed ID: 15533438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches for inhibition of mucus hypersecretion in asthma.
    Agrawal A; Mabalirajan U; Ram A; Ghosh B
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):188-92. PubMed ID: 19075982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The airway goblet cell.
    Rogers DF
    Int J Biochem Cell Biol; 2003 Jan; 35(1):1-6. PubMed ID: 12467641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.